Task: Answer the multiple choice question.
Query: Which compound exhibits a -1.205\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a CCc1cc(=O)oc2c(C)c(OCC(=O)NCc3ccccn3)ccc12
b CCOc1ccc(C2C(C(=O)c3cccs3)=C(O)C(=O)N2CCCn2ccnc2)cc1
c CCN(CC)S(=O)(=O)c1ccc(N2CCN(CCOc3ccc(OC)cc3)CC2)nc1
d O=C(CCC1CCCC1)N[C@@H](Cc1ccc(O)cc1)C(=O)O
e O=C(NCc1ccccc1)C1=C[C@H](c2ccc(Br)cc2)C[C@H](OCCCCO)O1
Answer: c. CCN(CC)S(=O)(=O)c1ccc(N2CCN(CCOc3ccc(OC)cc3)CC2)nc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)S(=O)(=O)c1ccc(N2CCN(CCOc3ccc(OC)cc3)CC2)nc1
CCN(CC)S(=O)(=O)c1ccc(N2CCN(CCOc3ccc(OC)cc3)CC2)nc1
N,N-diethyl-6-[4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl]pyridine-3-sulfonamide